Methoxymethane

Methoxymethane

SCHEMBL8323899

CC(C)(C)OC(C)(C)C.COC

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8913 0.89
Butane SCHEMBL4463544 0.84 ALDH1A1 (0.38) ALDH1A1TSHRTDP1
SCHEMBL15652979 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Potassium SCHEMBL183183 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL6504995 0.84 TSHR (0.55) ALDH1A1TSHRTDP1
Methane SCHEMBL30637 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Water SCHEMBL8067978 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL775104 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
Ethane SCHEMBL353672 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL30933076 0.84 ALDH1A1 (0.42) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022052936-A1 ARYL PROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF 南京海融医药科技股份有限公司 2022-03-17 WO claimed
US-20230002334-A1 TRPM8 MODULATORS GIVAUDAN SA (CH) 2023-01-05 US disclosed
EP-4065566-A1 TRPM8 MODULATORS Givaudan SA (CH) 2022-10-05 EP disclosed
CN-114761385-A TRPM8 modulators 奇华顿股份有限公司 2022-07-15 CN disclosed
WO-2021105261-A1 TRPM8 MODULATORS GIVAUDAN SA (CH) 2021-06-03 WO disclosed
WO-2021102896-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2021-06-03 WO disclosed
CN-107074829-B For inhibiting microsomal prostaglandin E2Novel methyl-piperidine compounds of synthetase-1 伊莱利利公司 2020-11-13 CN disclosed
WO-2020119507-A1 METHOD FOR CONTINUOUSLY PREPARING 5-CITALOPRAM DIOL 浙江华海药业股份有限公司 2020-06-18 WO disclosed
WO-2020010643-A1 METHOD FOR SYNTHESIZING VALSARTAN 浙江华海药业股份有限公司 2020-01-16 WO disclosed
US-20180250282-A1 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 LILLY CO ELI (US) 2018-09-06 US disclosed
US-9962375-B2 Methyl-piperidine compounds useful for inhibiting microsomal prostaglandin E2 synthase-1 ELI LILLY AND COMPANY (US) 2018-05-08 US disclosed
US-20170326128-A1 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 ELI LILLY AND COMPANY 2017-11-16 US disclosed
US-5902773-A PESTICIDES AND FUNGICIDES FORMED BY MULTISTAGE REACTIONS, WITTIG REACTION WITH BENZALDEHYDE BASF AKTIENGESELLSCHAFT (DE) 1999-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170326128-A1 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 PTGS1, PTGES, PTGER1 ALDH1A1 46/4885TSHR 3150/4885TDP1 2452/4885
US-20230002334-A1 TRPM8 MODULATORS TRPM8, TRPM7, TRPM2 ALDH1A1 2157/4885TSHR 1377/4885TDP1 3842/4885
US-20180250282-A1 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 PTGS1, PTGES, PTGER1 ALDH1A1 50/4885TSHR 3194/4885TDP1 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.